These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16028082)

  • 1. [The neurophysiology of cataplexy].
    Mayer G
    Nervenarzt; 2005 Dec; 76(12):1464, 1466-9. PubMed ID: 16028082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocretin and its emerging role as a target for treatment of sleep disorders.
    Cao M; Guilleminault C
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep transitions in hypocretin-deficient narcolepsy.
    Sorensen GL; Knudsen S; Jennum P
    Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
    Dauvilliers Y; Jennum P; Plazzi G
    Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory regulation in narcolepsy.
    Han F
    Sleep Breath; 2012 Mar; 16(1):241-5. PubMed ID: 21318258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
    Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy.
    Liblau RS; Vassalli A; Seifinejad A; Tafti M
    Lancet Neurol; 2015 Mar; 14(3):318-28. PubMed ID: 25728441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narcolepsy: pathophysiology and pharmacology.
    Nishino S
    J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of REM sleep-related episodes in children with type 1 narcolepsy.
    Antelmi E; Pizza F; Vandi S; Neccia G; Ferri R; Bruni O; Filardi M; Cantalupo G; Liguori R; Plazzi G
    Brain; 2017 Jun; 140(6):1669-1679. PubMed ID: 28472332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for narcolepsy.
    Abad VC; Guilleminault C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep.
    Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C
    Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.